Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by butein in RAW 264.7 cells

Biochemical and Biophysical Research Communications

Volumn 323, Issue 1, 2004, Pages 125-132

  Lee, Sung Hee ^a   Seo, Geom Seog ^a   Sohn, Dong Hwan ^a  

^a Wonkwang University   (South Korea)

Author keywords

v 3 integrin; Butein; Erk1 2 MAP kinase; Inducible nitric oxide synthase; Nuclear factor B; Osteopontin

Indexed keywords

ANTIINFLAMMATORY AGENT; BUTEIN; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; OSTEOPONTIN; VITRONECTIN RECEPTOR;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DNA BINDING; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; ENZYME INHIBITION; FLOW CYTOMETRY; INFLAMMATION; MACROPHAGE; MOUSE; NORTHERN BLOTTING; WESTERN BLOTTING;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; CELL NUCLEUS; CHALCONE; CHALCONES; CYCLOOXYGENASE 2; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; INFLAMMATION; INTEGRIN ALPHAVBETA3; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OSTEOPONTIN; PHOSPHORYLATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SIALOGLYCOPROTEINS;

EID: 4444373574     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.08.063     Document Type: Article

References (36)

1. D.G. Kang, A.S. Lee, Y.J. Mun, W.H. Woo, Y.C. Kim, E.J. Sohn, M.K. Moon, and H.S. Lee Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats Biol. Pharm. Bull. 27 2004 366 370
2. S.C. Chan, Y.S. Chang, J.P. Wang, S.C. Chen, and S.C. Kuo Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera Planta Med. 64 1998 153 158
3. J.C. Lee, K.T. Lim, and Y.S. Jang Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties Biochim. Biophys. Acta 1570 2002 181 191
4. E.B. Yang, K. Zhang, L.Y. Cheng, and P. Mack Butein, a specific protein tyrosine kinase inhibitor Biochem. Biophys. Res. Commun. 245 1998 435 438
5. E.B. Yang, Y.J. Guo, K. Zhang, Y.Z. Chen, and P. Mack Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives Biochim. Biophys. Acta 1550 2001 144 152
6. H.X. Xu, M. Wan, H. Dong, P.P. But, and L.Y. Foo Inhibitory activity of flavonoids and tannins against HIV-1 protease Biol. Pharm. Bull. 23 2000 1072 1076
7. S.W. Woo, S.H. Lee, H.C. Kang, E.J. Park, Y.Z. Zhao, Y.C. Kim, and D.H. Sohn Butein suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture J. Pharm. Pharmacol. 55 2003 347 352
8. S.H. Lee, J.X. Nan, Y.Z. Zhao, S.W. Woo, E.J. Park, T.H. Kang, G.S. Seo, Y.C. Kim, and D.H. Sohn The chalcone butein from Rhus verniciflua shows antifibrogenic activity Planta Med. 69 2003 990 994
9. C. Nathan Nitric oxide as a secretory product of mammalian cells FASEB J. 6 1992 3051 3064
10. R.M. Palmer, D.S. Ashton, and S. Moncada Vascular endothelial cells synthesize nitric oxide from l-arginine Nature 333 1988 664 666
11. C.J. Lowenstein, S.L. Hill, A. Lafond-Walker, J. Wu, G. Allen, M. Landavere, N.R. Rose, and A. Herskowitz Nitric oxide inhibits viral replication in murine myocarditis J. Clin. Invest. 97 1996 1837 1843
12. D.L. Duval, D.R. Miller, J. Collier, and R.E. Billings Characterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants Mol. Pharmacol. 50 1996 277 284
13. M.A. Marletta Nitric oxide synthase structure and mechanism J. Biol. Chem. 268 1993 12231 12234
14. Q.W. Xie, H.J. Cho, J. Calaycay, R.A. Mumford, K.M. Swiderek, T.D. Lee, A. Ding, T. Troso, and C. Nathan Cloning and characterization of inducible nitric oxide synthase from mouse macrophages Science 356 1992 225 228
15. A. Petros, D. Bennett, and P. Vallance Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock Lancet 338 1991 1557 1558
16. N. McCartney-Francis, J.B. Allen, D.E. Mizel, J.E. Albina, Q.W. Xie, C.F. Nathan, and S.M. Wahl Suppression of arthritis by an inhibitor of nitric oxide synthase J. Exp. Med. 178 1993 749 754
17. R. Kleemann, H. Rothe, V. Kolb-Bachofen, Q.W. Xie, C. Nathan, S. Martin, and H. Kolb Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats FEBS Lett. 328 1993 9 12
18. 15N]nitrate in biological fluids Anal. Biochem. 126 1982 131 138
19. A.H. Lo, Y.C. Liang, S.Y. Lin-Shiau, C.T. Ho, and J.K. Lin Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-κB in mouse macrophages Carcinogenesis 23 2002 983 991
20. H.H. Kim, M. Tharayil, and C.E. Rudd Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling J. Biol. Chem. 273 1998 296 301
21. L.G. Fischer, D.J. Horstman, K. Hahnenkamp, N.E. Kechner, and G.F. Rich Selective iNOS inhibition attenuates acetylcholine- and bradykinin-induced vasoconstriction in lipopolysaccharide-exposed rat lungs Anesthesiology 91 1999 1724 1732
22. J.A. Avontuur, F. Boomsma, A.H. van den Meiracker, F.H. de Jong, and H.A. Bruining Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock Circulation 99 1999 271 275
23. K.J. Tracey, and A. Cerami Tumor necrosis factor: a pleiotropic cytokine and therapeutic target Annu. Rev. Med. 45 1994 491 503
24. D.J. Wadleigh, S.T. Reddy, E. Kopp, S. Ghosh, and H.R. Herschman Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages J. Biol. Chem. 275 2000 6259 6266
25. G.N. Levy Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer FASEB J. 11 1997 234 247
26. S.C. Wong, M. Fukuchi, P. Melnyk, I. Rodger, and A. Giaid Induction of cyclooxygenase-2 and activation of nuclear factor-κB in myocardium of patients with congestive heart failure Circulation 98 1998 100 103
27. A. Hartner, M. Goppelt-Struebe, and K.F. Hilgers Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension Hypertension 31 1998 201 205
28. Q.W. Xie, Y. Kashiwabara, and C. Nathan Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase J. Biol. Chem. 269 1994 4705 4708
29. C.J. Lowenstein, E.W. Alley, P. Raval, A.M. Snowman, S.H. Snyder, S.W. Russell, and W.J. Murphy Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide Proc. Natl. Acad. Sci. USA 90 1993 9730 9734
30. N.R. Rice, and M.K. Ernst In vivo control of NF-κB activation by IκBα EMBO J. 12 1993 4685 4695
31. M.J. May, and S. Ghosh Signal transduction through NF-κB Immunol. Today 19 1998 80 88
32. H. Nakano, M. Shindo, S. Sakon, S. Nishinaka, M. Mihara, H. Yagita, and K. Okumura Differential regulation of IκB kinase alpha and beta by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1 Proc. Natl. Acad. Sci. USA 95 1998 3537 3542
33. D.T. Denhardt, and X. Guo Osteopontin: a protein with diverse functions FASEB J. 7 1993 1475 1482
34. C. Nathan, and Q.W. Xie Regulation of biosynthesis of nitric oxide J. Biol. Chem. 269 1994 13725 13728
35. S.M. Hwang, C.A. Lopez, D.E. Heck, C.R. Gardner, D.L. Laskin, J.D. Laskin, and D.T. Denhardt Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells J. Biol. Chem. 269 1994 711 715
36. H. Guo, C.Q. Cai, R.A. Schroeder, and P.C. Kuo Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages J. Immunol. 166 2001 1079 1086